Kate Haviland - Mar 1, 2024 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CHIEF EXECUTIVE OFFICER
Signature
/s/ Melissa Masse, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/6/2024, 04:18 PM
Previous filing
Jun 29, 2023
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Award $0 +40K +31.84% $0.00 166K Mar 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Award $0 +80K $0.00 80K Mar 1, 2024 Common Stock 80K $95.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the Reporting Person's receipt of grant of 40,000 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
F2 This option vests with respect to 1/48th of the shares underlying the option on April 1, 2024 and as to an additional 1/48th of the shares underlying the option each month thereafter.